Nishikawa, Taichiro

Resetting the transcription factor network reverses terminal chronic hepatic failure

Nishikawa, T., Bell, A., Brooks, J. M., Setoyama, K., Melis, M., Han, B., Fukumitsu, K., Handa, K., Tian, J., Kaestner, K. H., et al. (2015) · Journal of Clinical Investigation

Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

Cited by 124

Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus

Seko, Y., Sumida, Y., Tanaka, S., Mori, K., Taketani, H., Ishiba, H., Hara, T., Okajima, A., Umemura, A., Nishikawa, T., et al. (2017) · Hepatology Research

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 89

Role of cell‐cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C

Sekoguchi, S., Nakajima, T., Moriguchi, M., Jo, M., Nishikawa, T., Katagishi, T., Kimura, H., Minami, M., Itoh, Y., Kagawa, K., et al. (2007) · Journal of Gastroenterology and Hepatology

Telomeres, Telomerase, and SenescenceHepatitis C virus research

Cited by 67